卖什么
World's Earliest Test for Alzheimer's Biomarkers
商业模式拆解
买家：谁掌握预算？
未核实Clinics and memory-care providers administering the screening; older adults 65+ are the tested population.
触发点：什么让他们现在购买？
Alzheimer changes begin years before memory loss; FDA-approved Leqembi and Kisunla work best in early stages, so early identification matters.
工作流：什么输入变成什么输出？
Patient visits clinic, staff fit a VR headset, patient performs five eye-movement tasks (hold gaze, look toward, look away, respond as dots change, follow), infrared cameras record, staff check recording; results reviewed with clinician.
渠道：怎么接触到客户？
Delivered through clinics/staff-administered visits; Take the test CTA; admin@saccade.health contact.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2026 秋季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.